NASDAQ:PALI

Palisade Bio Stock Predictions

etoro logo Buy PALI
*Your capital is at risk
$1.93
+0.0700 (+3.76%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

PALI Prediction Chart

PALI Predictions History

Latest community submissions for PALI.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 20, 2026 $1.74 +4.89% $1.89 V 92.13% 1
Jan 20, 2026 $1.71 +3.06% $1.89 V 90.52% 1
Jan 20, 2026 Bullish $1.89 V 1
Dec 11, 2025 $2.02 -4.02% $2.20 X 91.82% 0
Dec 11, 2025 $2.05 -2.52% $2.20 X 93.27% 0
Dec 11, 2025 Bearish $2.20 X 0
Nov 24, 2025 Bullish $2.28 V 1
Nov 24, 2025 $2.04 -4.27% $2.28 X 89.44% 0
Nov 24, 2025 $2.07 -2.67% $2.28 X 90.93% 0
Nov 24, 2025 Bullish $2.28 X 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PALI with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT PALISADE BIO, INC.
Palisade Bio
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor that is intended to inhibit digestive enzyme activity and preserve gut integrity during int...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE